Citadel Advisors - CONTRAVIR PHARMACEUTICALS IN ownership

CONTRAVIR PHARMACEUTICALS IN's ticker is CTRVXXXX and the CUSIP is 21234W103. A total of 35 filers reported holding CONTRAVIR PHARMACEUTICALS IN in Q4 2017. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Citadel Advisors ownership history of CONTRAVIR PHARMACEUTICALS IN
ValueSharesWeighting
Q1 2018$31,000
-40.4%
136,810
-4.9%
0.00%
Q4 2017$52,000
+13.0%
143,898
+449.8%
0.00%
Q1 2017$46,00026,1730.00%
Other shareholders
CONTRAVIR PHARMACEUTICALS IN shareholders Q4 2017
NameSharesValueWeighting ↓
EAM Investors, LLC 670,593$3,401,0000.45%
Prospera Financial Services Inc 184,100$236,0000.05%
HighTower Advisors, LLC 1,047,731$1,257,0000.01%
TWO SIGMA SECURITIES, LLC 15,142$18,0000.01%
TEACHERS ADVISORS, LLC 298,781$1,820,0000.00%
TIAA CREF INVESTMENT MANAGEMENT LLC 724,455$4,412,0000.00%
Virtu KCG Holdings LLC 90,490$109,0000.00%
FIRST FOUNDATION ADVISORS 10,000$12,0000.00%
Acrospire Investment Management LLC 2,300$3,0000.00%
Balentine LLC 55$00.00%
View complete list of CONTRAVIR PHARMACEUTICALS IN shareholders